Synopsys Stock: The Price Tag Hides a Patient Investor’s Discount

The stock’s high multiple looks daunting, but a look at future earnings reveals a very different story about its price.

Synopsys (SNPS) finds itself at the center of an AI-driven semiconductor boom, providing the essential software that companies use to design the world’s most complex chips. That prime position comes with a premium price tag. On the surface, the stock looks expensive, trading at about 92.5 times its last twelve months of reported earnings. For many, the analysis stops there.

But that sticker price is misleading. The real story is the forward valuation discount, the way the multiple you pay falls on its own as earnings grow into the price.

What Patience Buys You

At today’s price of about $373.52, the multiple on the earnings analysts expect two years out, in 2027, is just 25.4 times. That’s a 73% lower multiple than the trailing figure, a steep discount for an investor willing to look ahead. A small caveat is that the trailing multiple is based on reported GAAP earnings, while forward estimates typically use a non-GAAP basis, which accounts for part of the drop. Still, the compression is significant. A patient holder is effectively buying the 2027 earnings stream at a far more conventional price.

And Synopsys is far from alone: which 10 S&P 500 stocks carry the biggest hidden forward discount? Our rankings sort the entire index by how little you are really paying for each name’s growth once the out-year earnings land.

Is The Growth Believable?

The honest question is not the price, but whether the growth that produces this discount will actually arrive. Here, the consensus forecast looks notably cautious. Analysts expect revenue to grow about 11.2% a year. That’s well below the 40% revenue growth the company actually delivered over the last twelve months. Management points to “continued AI-driven demand strength” as a key driver, with hyperscalers and chipmakers scaling up for complex AI designs. If that momentum continues, analyst estimates could prove conservative.

Crucially, analysts are not out on a limb. Management’s own guidance for 2026 non-GAAP earnings per share is about $14.8, almost perfectly aligned with the analyst consensus of $14.78 for the year. When the company’s own outlook corroborates the consensus, the foundation for that forward discount feels much firmer.

The Margin of Safety and the Reward

A stock priced for growth can be volatile. In past market shocks, Synopsys has fallen as much as 45% from its peak. The stock’s recent performance, which has seen it slide at times, underscores that this journey requires patience. That forward discount is your margin of safety, not your reward.

If the price never moves, you’d simply end up owning the stock at 25.4 times its 2027 earnings, proving you didn’t overpay. The actual reward comes from price appreciation, and that requires the market to continue paying a richer multiple as those earnings arrive. Consider a scenario where the multiple settles at about 59.0 times, roughly halfway between today’s level and that floor. On 2027 earnings, that would put the stock about 132% above today’s price. These are scenarios, not predictions, illustrating how the math works if the growth story holds.

The Real Price of Admission

By 2027, on these estimates, the multiple you are paying today compresses to an ordinary level. The premium you see is not the price you are really paying for the long term. If the growth arrives, you haven’t overpaid. If the market keeps valuing that growth, the stock price compounds with it. To see if the story is on track, watch the Design IP segment. Management believes the business “bottomed in Q1” and has “begun its recovery,” making its sequential progress a key indicator to follow.

And if it is exposure to software as a whole you want rather than this one name, a software ETF like IGV covers that theme.

What A Stock Is Worth And How Much To Own Are Different Questions

Valuation says what a stock might be worth; it says nothing about how much of your wealth should ride on it. How much damage any single position could do to your net worth is a question with a precise answer. The Trefis Wealth team computes it for investors professionally, with the same rules-based systematic discipline that runs our High Quality Portfolio. Request a free vulnerability audit of your biggest positions.